Immunicum AB: Invitation to Investor Events
November 22, 2017Invitation to Investor Events
Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events.
Aktiespararna Stora Aktiedagen in Gothenburg
Date: Monday, November 27, 2017
Presentation Time: 10:10-10:40 CET
Location: Svenska Mässan, Mässans Gata 8, Gothenburg
Please register to attend at https://www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg.
Immunicum Investor Event in Stockholm
Date: Thursday, November 30, 2017
Presentation Time: 18:00-19:00 CET
Location: United Spaces, Waterfront Building, Floor 2, Klarabergsviadukten 63, Stockholm
After the presentation, there is an opportunity to enjoy drinks and refreshments. Please register to attend by emailing firstname.lastname@example.org no later than Tuesday, November 28, 2017.
Carlos de Sousa, CEO, Immunicum
Telephone: +46 (0) 31 41 50 52
Hallvarsson & Halvarsson
Telephone: + 46 709 71 12 53
Telephone: +49 172 861 8540
The Company's Certified Adviser is Redeye AB
Telephone: +46 (0) 8 545 013 31
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Immunicum AB via Globenewswire